Well that was disappointing. 1H11 NPAT below 2H10 and revenue basically flat. I understand exchange rates made a difference but the company appears to be running out of momentum. Last few days action a case of buy the rumour, sell the news?
- Forums
- ASX - By Stock
- CST
- Ann: Half Yearly Report and Accounts
Ann: Half Yearly Report and Accounts , page-2
-
- There are more pages in this discussion • 28 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CST (ASX) to my watchlist
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online